Literature DB >> 19733533

Pluripotent stem cells and disease modeling.

Alan Colman1, Oliver Dreesen.   

Abstract

Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) can theoretically be converted into any somatic cell type. hESCs and hiPSCs carrying genetic defects can now be produced to model diseases in vitro. We suggest several guiding principles to help ensure an optimal fit between technology and disease.

Entities:  

Mesh：

Year:  2009        PMID： 19733533     DOI： 10.1016/j.stem.2009.08.010

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  36 in total

1.  Generation of functional hepatic cells from pluripotent stem cells.

Authors:  Songyan Han; Alice Bourdon; Wissam Hamou; Noelle Dziedzic; Orit Goldman; Valerie Gouon-Evans
Journal:  J Stem Cell Res Ther       Date:  2012-08-15

Review 2.  Impact of induced pluripotent stem cells on the study of central nervous system disease.

Authors:  Paige E Cundiff; Stewart A Anderson
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

3.  Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells.

Authors:  Daniel Paull; Ana Sevilla; Hongyan Zhou; Aana Kim Hahn; Hesed Kim; Christopher Napolitano; Alexander Tsankov; Linshan Shang; Katie Krumholz; Premlatha Jagadeesan; Chris M Woodard; Bruce Sun; Thierry Vilboux; Matthew Zimmer; Eliana Forero; Dorota N Moroziewicz; Hector Martinez; May Christine V Malicdan; Keren A Weiss; Lauren B Vensand; Carmen R Dusenberry; Hannah Polus; Karla Therese L Sy; David J Kahler; William A Gahl; Susan L Solomon; Stephen Chang; Alexander Meissner; Kevin Eggan; Scott A Noggle
Journal:  Nat Methods       Date:  2015-08-03       Impact factor: 28.547

Review 4.  Biology and mechano-response of tendon cells: Progress overview and perspectives.

Authors:  Hui B Sun; Christoph Schaniel; Daniel J Leong; James H-C Wang
Journal:  J Orthop Res       Date:  2015-04-28       Impact factor: 3.494

5.  Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes.

Authors:  Stormy J Chamberlain; Pin-Fang Chen; Khong Y Ng; Fany Bourgois-Rocha; Fouad Lemtiri-Chlieh; Eric S Levine; Marc Lalande
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

6.  Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathway.

Authors:  Mengfei Chen; He Zhang; Jie Wu; Liang Xu; Di Xu; Jingnan Sun; Yixin He; Xin Zhou; Zhaojing Wang; Lifang Wu; Shaokun Xu; Jinsong Wang; Shu Jiang; Xiangjun Zhou; Andrew R Hoffman; Xiang Hu; Jifan Hu; Tao Li
Journal:  Biomaterials       Date:  2012-05-09       Impact factor: 12.479

7.  Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells.

Authors:  Akihiro Asai; Eitaro Aihara; Carey Watson; Reena Mourya; Tatsuki Mizuochi; Pranavkumar Shivakumar; Kieran Phelan; Christopher Mayhew; Michael Helmrath; Takanori Takebe; James Wells; Jorge A Bezerra
Journal:  Development       Date:  2017-03-15       Impact factor: 6.868

Review 8.  Stem cell therapy: an exercise in patience and prudence.

Authors:  Huan-Ting Lin; Makoto Otsu; Hiromitsu Nakauchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

9.  Establishment, characterization, and differentiation of a karyotypically normal human embryonic stem cell line from a trisomy-affected embryo.

Authors:  Arundhati Mandal; Sheena Mathew; Debapriya Saha; Chandra Viswanathan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-12-14       Impact factor: 2.416

Review 10.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.